Fig. 4
From: Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
Minimax, admissible and optimal design for (p0, p1, α, β) = (0.05, 0.25, 0.05, 0.10) based on Fleming’s design
Fig. 4 | BMC Medical Research Methodology